Authors' reply-A sensitivity analysis of the RAPIDO clinical trial.

Autor: Dijkstra EA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: e.a.dijkstra@umcg.nl., Zwart WH; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Putter H; Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands., Marijnen CAM; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands., Nilsson PJ; Department of Surgery, Karolinska University Hospital, Stockholm, Sweden., van de Velde CJH; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., van Etten B; Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Glimelius B; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Jazyk: angličtina
Zdroj: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Apr; Vol. 34 (4), pp. 446-447. Date of Electronic Publication: 2022 Dec 26.
DOI: 10.1016/j.annonc.2022.12.012
Abstrakt: Competing Interests: Disclosure PJN reports honoraria from Ethicon, Johnson & Johnson and Amgen. GAPH reports consulting fees from Roche, MSD, Amgen and Novartis; consulting fees and research support to their institution from Bristol Myers Squibb; and research support to their institution from Seerave Foundation. CJHvdV was partially funded by the EU’s Horizon 2020 research and innovation program under a Marie SkłodowskaCurie grant award (H2020MSCAITN2019, grant agreement number 857894; project acronym: CAST). BG reports research support from the Swedish Cancer Society. All other authors have declared no conflicts of interest.
Databáze: MEDLINE